Your Followed Topics

89.22%
health1h ago

Key facts: Breckenridge launches generic tofacitinib; Pfizer licenses Chai

Key facts: Breckenridge launches generic tofacitinib; Pfizer licenses Chai Open in Tradingview.com
Highlights
  • Breckenridge launched a generic tofacitinib tablet, challenging Pfizer’s Xeljanz in the RA market.
  • The generic’s market entry may increase supply and put pricing pressure on Pfizer’s RA drug sales.
  • Pfizer licensed Chai Discovery’s AI platform to speed drug discovery.

Virality Score Timeline

Vote 0
0

Related Topics

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 519 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement